About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
30 Jan,2026
Zylox-Tonbridge Announces Positive Profit Alert: Net Profit Expected to Increase by Approximately 140% Year-on-Year in FY2025, with Revenue Exceeding RMB 1.05 Billion
Hong Kong, January 29, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, the “Company” or “Zylox-Tonbridge”) today announced a positive profit alert for the fiscal year ended Decem...
more
16 Jan,2026
Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market
Marks a major milestone in Zylox-Tonbridge’s long-term commitment to global expansionBuilds an integrated global commercialization platform to accelerate Zylox-Tonbridge’s adoption of innovative va...
more
12 Jan,2026
Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy
Zhuhai, China — January 11, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Invest...
more
27 Aug,2025
Seeing is Believing | First Case of Pantheris Completed in Boao, Hainan
BOAO, Hainan, China – August 24, 2025 — Zylox-Tonbridge today announced that a vascular surgery team led by Prof. Jiaxuan Feng, Chief of Vascular Surgery at Ruijin Hospital affiliated with the Shang...
more
24 Jul,2025
Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit
HANGZHOU, China, July 23, 2025 – Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, “Zylox-Tonbridge” or the “Company”), a leading medical device company in China’s peripheral and neurova...
more
28 May,2025
2024 Environmental, Social and Governance Report
more
